Nikko Asset Management Americas, Inc. Beam Therapeutics Inc. Transaction History
Nikko Asset Management Americas, Inc.
- $9.23 Billion
- Q3 2025
A detailed history of Nikko Asset Management Americas, Inc. transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Nikko Asset Management Americas, Inc. holds 4,830,738 shares of BEAM stock, worth $106 Million. This represents 1.27% of its overall portfolio holdings.
Number of Shares
4,830,738
Previous 4,726,799
2.2%
Holding current value
$106 Million
Previous $80.4 Million
45.82%
% of portfolio
1.27%
Previous 0.85%
Shares
20 transactions
Others Institutions Holding BEAM
# of Institutions
250Shares Held
95MCall Options Held
910KPut Options Held
583K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11MShares$243 Million1.88% of portfolio
-
Farallon Capital Management LLC San Francisco, CA10.1MShares$222 Million1.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.25MShares$204 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$168 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.4.83MShares$106 Million0.07% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.55B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...